Solid Tumors With PTCH1 Loss-of-function Mutations
1 clinical trials · Condition
◉ Watch Solid Tumors With PTCH1 Loss-of-function Mutations
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations (NCT05199584) | Endeavor Biomedicines, Inc. | 2022-05-24 |
Track Solid Tumors With PTCH1 Loss-of-function Mutations automatically
Every clearance here is in the API, with alerts when new ones post.